Press Releases

Alfa Chemistry Unveils Revitalized Strong/Weak Acid Cation Resin and Base Anion Resin Lineup

BioIVT Webinar Will Discuss How to Manage Uncooperative Drugs in In Vitro Transporter Research

This webinar will present practical strategies to achieve definitive results when researching unstable, sticky, or insoluble compounds.

uMed Partners with The Michael J. Fox Foundation to Support Wide-scale Study Exploring Link Between Smell Loss and Parkinson’s

Health and research tech company uMed is partnering with the Michael J. Fox foundation to run a smell test study to investigate the link between loss of smell and Parkinson’s disease. uMed’s technology and consumer-based marketing techniques will help the Michael J. Fox Foundation overcome traditional barriers to engaging clinical trial volunteers and reach a large, diverse patient cohort to accelerate the pace of research and access to potential breakthroughs.

Ann Graham, Founder of MIB Agents, Joins NCCN Guidelines Panel

Ann Graham, Founder and Executive Director of MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to making it better for its community of patients, caregivers, doctors, and researchers, has officially joined the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Bone Cancer, in the role of patient advocate.

CD ComputaBio Launches Revolutionary Antibody De Novo Design Service Pioneering Precision Medicine with AI

CD ComputaBio Unveils Cutting-Edge Advances in Antibody Drug Design and Development

Daptomycin ReadyMade™ Solution to Power Up Spectrum and Microbiology Applications

CD Formulation Demonstrates Expertise in CAR-T and CAR-NK Cell Development for Drug Delivery Systems

Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer

Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that Brian Schubmehl has joined the company as Chief Human Resources Officer.

Huateng Pharma to Attend CPHI Barcelona 2023

Huateng Pharma will be attending CPhI Worldwide, Booth 3C02, Hall 3.

SMi Systems secures UK patent for breakthrough single molecule imaging capabilities

SMi Systems has secured a patent from the UK Intellectual Property Office for the single-molecule imaging technologies that underpin its super-resolution multi-omic platform.

Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart

Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart Prof Deborah Ashby to give the 2023 Sally Hollis Memorial Lecture in Macclesfield

Belong.Life Launches New Conversational AI SaaS Solution for Cancer Clinical Trial Matching and Recruitment

Tara is a SaaS-based conversational AI cancer clinical trial matching platform for health providers and contract research organizations (CROs). The solution is designed to accelerate the process of matching patients with eligible clinical trials, enabling increased recruitment at significantly lower costs. Tara is the second product in Belong’s AI Health Mentor suite of solutions.

Torx® Software announces global drug discovery collaboration with CDD Vault®

Torx® Software Limited has launched a major international collaboration with CDD Vault, which will create a shared digital ecosystem for drug discovery data

Launch of high-quality (pre-clinical) enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutics

Takara Bio Europe has announced the launch of new high-quality grade mRNA production enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.

Tower continues innovation streak with new product launch at CPHI Barcelona

Temperature-controlled container specialist, Tower Cold Chain will be exhibiting its latest concept and products at the world’s largest pharmaceutical event, CPHI.

BioIVT Completes XenoTech Integration, Highlights Expanded ADME-Tox Research Services at the North American ISSX Meeting

BioIVT has implemented new tiered ‘fit-for-purpose’ study designs for metabolism, drug-drug interaction, and transporter programs.

New Educational Initiative, Clinical Trials For All, to Drive More Understanding, Participation, and Diversity

Amerigo Scientific Releases FSB Solution Products to Expedite Alzheimer’s Disease Research